José Palacios

Active 1979–2026

Also published as
JOSÉ PALACIOS · Jose Palacios
192
Papers
33,425
Citations
105
h-index
182
i10-index

Citations

Citations per year for José Palacios1932: 2 citations1971: 1 citations1980: 3 citations1981: 22 citations1982: 17 citations1983: 36 citations1984: 67 citations1985: 82 citations1986: 139 citations1987: 142 citations1988: 178 citations1989: 165 citations1990: 166 citations1991: 143 citations1992: 122 citations1993: 175 citations1994: 135 citations1995: 166 citations1996: 128 citations1997: 161 citations1998: 127 citations1999: 166 citations2000: 169 citations2001: 160 citations2002: 122 citations2003: 161 citations2004: 187 citations2005: 211 citations2006: 206 citations2007: 258 citations2008: 325 citations2009: 279 citations2010: 327 citations2011: 357 citations2012: 289 citations2013: 303 citations2014: 257 citations2015: 297 citations2016: 234 citations2017: 209 citations2018: 185 citations2019: 584 citations2020: 672 citations2021: 663 citations2022: 451 citations2023: 314 citations2024: 380 citations2025: 177 citations2026: 5 citations1933–1970: no citations, so these years are not shown1972–1979: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,324 citing papers, 29.3% of this breakdownUnited Kingdom: 830 citing papers, 7.3% of this breakdownChina: 805 citing papers, 7.1% of this breakdownSpain: 607 citing papers, 5.4% of this breakdownItaly: 532 citing papers, 4.7% of this breakdownCanada: 499 citing papers, 4.4% of this breakdownGermany: 484 citing papers, 4.3% of this breakdownFrance: 476 citing papers, 4.2% of this breakdownJapan: 361 citing papers, 3.2% of this breakdownAustralia: 306 citing papers, 2.7% of this breakdownNetherlands: 294 citing papers, 2.6% of this breakdownSweden: 244 citing papers, 2.1% of this breakdown
0%29.3%Other 22.7%

Fields

  • Biochemistry, Genetics and Molecular Biology37%
  • Medicine35.2%
  • Neuroscience19.1%
  • Psychology2.7%
  • Immunology and Microbiology2.1%
  • Computer Science1.3%
  • Other2.6%

Topics

  • Neurotransmitter Receptor Influence on Behavior4.9%
  • Neuroscience and Neuropharmacology Research4.8%
  • Receptor Mechanisms and Signaling3.9%
  • Cancer Cells and Metastasis3.6%
  • Breast Cancer Treatment Studies2.4%
  • Wnt/β-catenin signaling in development and cancer2.1%
  • Other78.3%

Coauthors

All papers

Open in search
  1. Breast cancer prognostic classification in the molecular era: the role of histological grade

    Authors: , , , , , , , , , , , , , , , , , - Breast Cancer Research 2010 cited by 992

  2. Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francesmary Modugno, Gregg Nelson, Jan Lubiński, Janusz Menkiszak, Jennifer Alsop, Jenny Lester, Jesús García-Donás, Jill Nation, Jillian A. Hung, José Palacios, Joseph H. Rothstein, Joseph L. Kelley, Jurandyr Moreira de Andrade, Luis A. Díaz‐Robles, Maria P. Intermaggio, Martin Widschwendter, Matthias W. Beckmann, Matthias Ruebner, Mercedes Jimenez‐Liñan, Naveena Singh, Oleg Oszurek, Paul R. Harnett, Peter Rambau, Hans‐Peter Sinn, Philipp Wagner, Prafull Ghatage, Raghwa Sharma, Robert P. Edwards, Roberta B. Ness, Sandra Oršulić, Sara Y. Brucker, Sharon E. Johnatty, Teri A. Longacre, Ursula Eilber, Valerie McGuire, Weiva Sieh, Yanina Natanzon, Zheng Li, Alice S. Whittemore, Anna DeFazio, Annette Staebler, Beth Y. Karlan, C. Blake Gilks, David D.L. Bowtell, Estrid Høgdall, Francisco José Cândido dos Reis, Helen Steed, Ian Campbell, Jacek Gronwald, Javier Benı́tez, Jennifer M. Koziak, Jenny Chang‐Claude, Kirsten B. Moysich, Linda E. Kelemen, Linda S. Cook, Marc T. Goodman, María J. García, Peter A. Fasching, Stefan Kommoss, Suha Deen, Susanne K. Kjær, Usha Menon, James D. Brenton, Paul D.P. Pharoah, Georgia Chenevix‐Trench, David G. Huntsman, Stacey J. Winham, Martin Köbel, Susan J. Ramus - JAMA Oncology 2017 cited by 404

  3. Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype

    Authors: , , , , , - Cancer Research 2008 cited by 1,074

  4. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

    Authors: , , , , , , , , , , , , , , , , , , - Modern Pathology 2010 cited by 674

  5. Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial

    Authors: , , , , , , , , , , , , , - The Lancet Infectious Diseases 2017 cited by 219

  6. PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular Markers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip S. Bernard, Miguel Martín - BMC Medical Genomics 2012 cited by 343

  7. Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness

    Authors: , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2019 cited by 126

  8. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors

    Authors: , - Brain Research 1985 cited by 1,855

  9. SIRT1 contributes to telomere maintenance and augments global homologous recombination

    Authors: , , , , , - The Journal of Cell Biology 2010 cited by 250

  10. Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Louise A. Brinton, Michael E. Carney, Yoke-Eng Chiew, Kara L. Cushing‐Haugen, Cezary Cybulski, Darren Ennis, Sián Fereday, Renée T. Fortner, Jesús García-Donás, Aleksandra Gentry‐Maharaj, Rosalind Glasspool, Teodora Goranova, Casey S. Greene, Paul Haluska, Holly R. Harris, Joy Hendley, Brenda Y. Hernandez, Esther Herpel, Mercedes Jimenez‐Liñan, Chloe Karpinskyj, Scott H. Kaufmann, Gary L. Keeney, Catherine J. Kennedy, Martin Köbel, Jennifer M. Koziak, Melissa C. Larson, Jenny Lester, Liz-Anne Lewsley, Jolanta Lissowska, Jan Lubiński, Hugh Luk, Geoff Macintyre, Sven� Mahner, Iain A. McNeish, Janusz Menkiszak, Nikilyn Nevins, Ana Osório, Oleg Oszurek, José Palacios, Samantha Hinsley, Celeste Leigh Pearce, Malcolm C. Pike, Anna Piskorz, Isabelle Ray‐Coquard, Valerie Rhenius, Cristina Rodríguez‐Antona, Raghwa Sharma, Mark E. Sherman, Dilrini De Silva, Naveena Singh, Hans‐Peter Sinn, Dennis J. Slamon, Honglin Song, Helen Steed, Euan A. Stronach, Pamela J. Thompson, Aleksandra Tołoczko, Britton Trabert, Nadia Traficante, Chiu-Chen Tseng, Martin Widschwendter, Lynne R. Wilkens, Stacey J. Winham, Boris Winterhoff, Alicia Beeghly‐Fadiel, Javier Benı́tez, Andrew Berchuck, James D. Brenton, Robert Brown, Jenny Chang‐Claude and 25 more - Clinical Cancer Research 2020 cited by 75

  11. A High-Throughput Study in Melanoma Identifies Epithelial-Mesenchymal Transition as a Major Determinant of Metastasis

    Authors: , , , , , , , , , , , , , , - Cancer Research 2007 cited by 339

  12. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

    Authors: , , , , , , , , , , , - Molecular Cancer 2010 cited by 195

  13. Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study

    Authors: , , , , , , , , , - European Journal of Clinical Microbiology & Infectious Diseases 2019 cited by 80

  14. The Mre11/Rad50/Nbs1 Complex Limits Adeno-Associated Virus Transduction and Replication

    Authors: , , , , , - Journal of Virology 2007 cited by 128

  15. Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , - Oncotarget 2016 cited by 118

  16. CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas P. Conrads, Linda S. Cook, Penny Coulson, Madeleine Courtney‐Brooks, Daniel W. Cramer, Philip Crowe, Julie M. Cunningham, Cezary Cybulski, Kathleen M. Darcy, Mona A. El‐Bahrawy, Esther Elishaev, Ramona Erber, Rhonda Farrell, Sián Fereday, Anna Fischer, María J. García, Simon A. Gayther, Aleksandra Gentry‐Maharaj, C. Blake Gilks, AOCS Group, Marcel Grube, Paul R. Harnett, Shariska P. Harrington, Philipp Harter, Arndt Hartmann, Jonathan L. Hecht, Sebastian Heikaus, Alexander Hein, Florian Heitz, Joy Hendley, Brenda Y. Hernandez, Susanna Hernando Polo, Sabine Heublein, Akira Hirasawa, Estrid Høgdall, Claus Høgdall, Hugo M. Horlings, David G. Huntsman, Tomasz Huzarski, Andrea Jewell, Mercedes Jimenez‐Liñan, Michael E. Jones, Scott H. Kaufmann, Catherine J. Kennedy, Dineo Khabele, F. Kommoss, Roy F.P.M. Kruitwagen, Diether Lambrechts, Nhu D. Le, Marcin Lener, Jenny Lester, Yee Leung, Anna Linder, Liselore Loverix, Jan Lubiński, Rashna Madan, G. Larry Maxwell, Francesmary Modugno, Susan L. Neuhausen, Alexander Olawaiye, Siel Olbrecht, Sandra Oršulić, José Palacios, Celeste Leigh Pearce, Malcolm C. Pike, Carmel M. Quinn, Ganendra Raj Mohan, Cristina Rodríguez‐Antona, Matthias Ruebner, Andy Ryan and 48 more - Cancer 2022 cited by 45

  17. Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors

    Authors: , , - Molecular Brain Research 1994 cited by 877

  18. A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition

    Authors: , , , , , , , , , , , , , , , , - Nature Genetics 2006 cited by 292

  19. FGFR1 Emerges as a Potential Therapeutic Target for Lobular Breast Carcinomas

    Authors: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2006 cited by 269

  20. Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates

    Authors: , , , , , , , - Brain Research 1990 cited by 264

  21. Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and [3H]rolipram binding autoradiography

    Authors: , , , , , - Journal of Chemical Neuroanatomy 2000 cited by 228

  22. Δ9-Tetrahydrocannabinol Inhibits Cell Cycle Progression in Human Breast Cancer Cells through Cdc2 Regulation

    Authors: , , , , - Cancer Research 2006 cited by 221

  23. Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer’s disease brains examined by in situ hybridization

    Authors: , , , , , - Experimental Neurology 2003 cited by 133

  24. Morphological and molecular heterogeneity of epithelial ovarian cancer: Therapeutic implications

    Authors: , , , , - European Journal of Cancer Supplements 2020 cited by 42